Location: Austria
Synced from ClinicalTrials.gov · August 09, 2026
Clinical studies recruiting near Austria
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Nitrate, Exercise and Vascular Function in Midlife Women NA · University of Vienna · NCT06527248 Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery NA · Medical University Innsbruck · NCT05931783 Observational Study Protocol: LIVER-R Phase N/A · AstraZeneca · NCT06252753 Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure NA · University Hospital, Geneva · NCT06207383 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis Phase 2 · Sanofi · NCT06867094 Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) Phase N/A · Insel Gruppe AG, University Hospital Bern · NCT01257269 Austrian PBC Registry Phase N/A · Medical University of Vienna · NCT07598669 Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Phase 3 · CSL Behring · NCT07080905 A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma Phase 2/Phase 3 · University of Birmingham · NCT05991388 A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit Phase 1 · eleva GmbH · NCT07483827 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia Phase 3 · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) Phase 3 · Merck Sharp & Dohme LLC · NCT06393374 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in Phase 3 · Pfizer · NCT06758401 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients Phase 2 · Miltenyi Biomedicine GmbH · NCT04844866 Diabetes Registry Graz for Biomarker Research Phase N/A · Medical University of Graz · NCT05324488 XEN Glaucoma Gel Stent Versus Trabeculectomy NA · Prof. Dr. Herbert Reitsamer · NCT05439161 Predication of Arterial Stiffness in Healthy Adults by Oral Health and Chewing Assessments NA · VASCage GmbH · NCT07736222 The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention NA · Medical University of Graz · NCT07588282 Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma Phase 3 · Vastra Gotaland Region · NCT06419946 The DRAGON 2 Trial NA · Maastricht University · NCT05428735 Smartphone Based Digital Screening for Aortic Valve Stenosis Phase N/A · Medical University Innsbruck · NCT07284550 STOP-HAE: A Phase 3 Study of ADX-324 in HAE Phase 3 · ADARx Pharmaceuticals, Inc. · NCT06960213 Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastat NA · Medical University of Vienna · NCT02971358 First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve NA · Epygon · NCT04775108 The Medacta International SMS Post-Marketing Surveillance Study Phase N/A · Medacta International SA · NCT02748408 Exercise Intensity and Muscle Recovery in Statin Users NA · Raffaele Mazzolari · NCT07563452 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) Phase 3 · PedAL BCU, LLC · NCT05183035 Randomization of Single vs Multiple Arterial Grafts NA · Weill Medical College of Cornell University · NCT03217006 M-ARS ACL Post-marketing Surveillance Study Phase N/A · Medacta International SA · NCT04462458
Look up another city
Look up another condition